New SAMHSA Publication Highlights Medicaid Impact
Report Focuses on Persons With Mental Health, Substance Use Disorders
SAMHSA has released a new report that underscores the continuing impact of Medicaid in providing access and care for persons with mental health conditions and substance use disorders.
The report, Analyses of MAX Claims: SAMHSA Fee-for-Service Spending Estimates, Medicare-Medicaid Enrollee Analysis, and Managed Care Summary, from SAMHSA's Center for Financing Reform and Innovation, includes information on Medicaid fee-for-service spending for prescription drugs and provider type for all Medicaid enrollees. It describes spending for Medicare-Medicaid enrollees as compared with those who are not dually eligible. The report also describes an approach to determine spending for enrollees receiving care through managed care organizations.
This report, along with future reports on MAX data from subsequent years, will help policymakers, program staff, and providers better understand spending on and utilization of services for mental health and substance use disorders. The report also will help SAMHSA to develop more precise estimates of state and federal spending on behavioral health.
Men of substance (abuse): how tech moguls drug their way through the day From Steve Jobs through Elon Musk to Google's Sergey Brin, a pattern emerges linking top executives to illicit drug use, often starting with consumption of small doses to enhance creativity in the workplace and eventually leading to secretive drug parties, with senior Tesla and SpaceX managers reporting feeling pressured by owner Musk to join these parties, fearing for their professional futures if they refuse Tzippy Shmilovitz, New York|02.24.24 | 13:00
Hace 1 hora